Biblio

Export 135 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
M. Timmers, Barão, S., Van Broeck, B., Tesseur, I., Slemmon, J., de Waepenaert, K., Bogert, J., Shaw, L. M., Engelborghs, S., Moechars, D., Mercken, M., Van Nueten, L., Tritsmans, L., De Strooper, B., and Streffer, J. Rolf, “BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1437-1449, 2017.
J. Timsina, Gomez-Fonseca, D., Wang, L., Do, A., Western, D., Álvarez, I., Aguilar, M., Pastor, P., Henson, R. L., Herries, E., Xiong, C., Schindler, S. E., Fagan, A. M., Bateman, R. J., Farlow, M., Morris, J. C., Perrin, R., Moulder, K., Hassenstab, J., Chhatwal, J., Mori, H., Sung, Y. Ju, and Cruchaga, C., “Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.”, J Alzheimers Dis, vol. 89, no. 1, pp. 193-207, 2022.
M. Toepper, “Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience.”, J Alzheimers Dis, vol. 57, no. 2, pp. 331-352, 2017.
A. Tofiq, Zetterberg, H., Blennow, K., Basun, H., Cederholm, T., Eriksdotter, M., Faxen-Irving, G., Hjorth, E., Jernerén, F., Schultzberg, M., Wahlund, L. - O., Palmblad, J., and Freund-Levi, Y., “Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1291-1301, 2021.
S. Tok, Ahnaou, A., and Drinkenburg, W., “Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression.”, J Alzheimers Dis, vol. 88, no. 3, pp. 809-836, 2022.
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., “APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
M. Tombini, Sicari, M., Pellegrino, G., Ursini, F., Insardá, P., and Di Lazzaro, V., “Nutritional Status of Patients with Alzheimer's Disease and Their Caregivers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1619-1627, 2016.
T. Tomoto, Liu, J., Tseng, B. Y., Pasha, E. P., Cardim, D., Tarumi, T., Hynan, L. S., C Cullum, M., and Zhang, R., “One-Year Aerobic Exercise Reduced Carotid Arterial Stiffness and Increased Cerebral Blood Flow in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 80, no. 2, pp. 841-853, 2021.
M. Tong, Deochand, C., Didsbury, J., and de la Monte, S. M., “T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
Z. Tong, Wang, W., Luo, W., Lv, J., Li, H., Luo, H., Jia, J., and He, R., “Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1031-1038, 2017.
S. Toniolo, Scarioni, M., Di Lorenzo, F., Hort, J., Georges, J., Tomic, S., Nobili, F., and Frederiksen, K. Steen, “Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.”, J Alzheimers Dis, vol. 82, no. 3, pp. 883-898, 2021.
S. Toniolo, Di Lorenzo, F., Scarioni, M., Frederiksen, K. Steen, and Nobili, F., “Is the Frontal Lobe the Primary Target of SARS-CoV-2?”, J Alzheimers Dis, vol. 81, no. 1, pp. 75-81, 2021.
E. Tönnies and Trushina, E., “Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1105-1121, 2017.
J. Toombs, Foiani, M. S., Paterson, R. W., Heslegrave, A., Wray, S., Schott, J. M., Fox, N. C., Lunn, M. P., Blennow, K., and Zetterberg, H., “Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration.”, J Alzheimers Dis, vol. 56, no. 3, pp. 885-891, 2017.
A. Toots, Littbrand, H., Boström, G., Hörnsten, C., Holmberg, H., Lundin-Olsson, L., Lindelöf, N., Nordström, P., Gustafson, Y., and Rosendahl, E., “Effects of Exercise on Cognitive Function in Older People with Dementia: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 1, pp. 323-332, 2017.
S. Toppala, Ekblad, L. L., Lötjönen, J., Helin, S., Hurme, S., Johansson, J., Jula, A., Karrasch, M., Koikkalainen, J., Laine, H., Parkkola, R., Viitanen, M., and Rinne, J. O., “Midlife Insulin Resistance as a Predictor for Late-Life Cognitive Function and Cerebrovascular Lesions.”, J Alzheimers Dis, vol. 72, no. 1, pp. 215-228, 2019.
S. Toppala, Ekblad, L. L., Viitanen, M., Rinne, J. O., and Jula, A., “Impaired Early Insulin Response to Glucose Load Predicts Episodic Memory Decline: A 10-Year Population-Based Cohort Follow-Up of 45-74-Year-Old Men and Women.”, J Alzheimers Dis, vol. 92, no. 1, pp. 349-359, 2023.
A. Torrens-Burton, Basoudan, N., Bayer, A. J., and Tales, A., “Perception and Reality of Cognitive Function: Information Processing Speed, Perceived Memory Function, and Perceived Task Difficulty in Older Adults.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1601-1609, 2017.
F. M. Torres-Cruz, Rodríguez-Cruz, F., Escobar-Herrera, J., Barragán-Andrade, N., Basurto-Islas, G., Ripova, D., Avila, J., and Garcia-Sierra, F., “Expression of Tau Produces Aberrant Plasma Membrane Blebbing in Glial Cells Through RhoA-ROCK-Dependent F-Actin Remodeling.”, J Alzheimers Dis, vol. 52, no. 2, pp. 463-82, 2016.
A. Tort-Merino, Valech, N., Peñaloza, C., Grönholm-Nyman, P., León, M., Olives, J., Estanga, A., Ecay-Torres, M., Fortea, J., Martínez-Lage, P., Molinuevo, J. L., Laine, M., Rodríguez-Fornells, A., and Rami, L., “Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.”, J Alzheimers Dis, vol. 58, no. 3, pp. 855-870, 2017.
R. Tortelli, Lozupone, M., Guerra, V., Barulli, M. Rosaria, Imbimbo, B. P., Capozzo, R., Grasso, A., Tursi, M., Di Dio, C., Sardone, R., Giannelli, G., Seripa, D., Misciagna, G., Panza, F., and Logroscino, G., “Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.”, J Alzheimers Dis, vol. 59, no. 1, pp. 121-130, 2017.
G. Tosto, Monsell, S. E., Hawes, S. E., Bruno, G., and Mayeux, R., “Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1085-93, 2016.
K. Toups, Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Jarrett, M., and Bredesen, D. E., “Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1411-1421, 2022.
B. Tousi, “Dementia Care in the Time of COVID-19 Pandemic.”, J Alzheimers Dis, vol. 76, no. 2, pp. 475-479, 2020.
A. R. Trammell, McDaniel, D. J., Obideen, M., Okafor, M., Thomas, T. L., Goldstein, F. C., Shaw, L. M., and Hajjar, I. M., “Perceived Stress is Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in African Americans with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 77, no. 2, pp. 843-853, 2020.

Pages